PHARLEX® pharma license exchange

Who Attends PHARLEX®?

Screening:	The success of the PHARLEX® pharma license exchange is measured by the opportunities of each participant to establish relationships with relevant people and companies. To achieve this, each participant is carefully screened to ensure that only executives with genuine licensing mandates and objectives are admitted. To our knowledge, PHARLEX® is the only pharma and biotech partnering event that in fact rejects registrations from companies that do not fit with the purpose of the forum.


Common purpose:	The pre-screening of the participants ensures that all participants share a common purpose, namely to explore the best licensing opportunities and to discover prospective partnerships.


Decision-makers:	PHARLEX® was designed for decision makers in pharma and biotech companies, from 'Big Pharma' to 'Start-Ups'. We bring the right people together, and we set the stage for development of the personal relationships that constitute the universal basis for successful partnership deals.


World-wide reach:	PHARLEX® is a North American partnering forum, which embraces pharmaceuticals and biotechnology as global industries. The geographical distribution of the companies attending PHARLEX® to date is approximately 60%, 30% and 10% for North America, Europe and the rest of the world, respectively, the latter including Latin America, Asia, the Middle East and Africa. For a complete list of countries that have been represented at PHARLEX®, please click here: Global Reach


Companies:	The companies attending PHARLEX® spans the entire industry, from the world's largest pharmaceutical companies (eg. Pfizer) to small, start-up biotech companies. In addition, PHARLEX® is the must-attend partnering forum for mid-sized companies with specific therapeutic or geographical focus. For a complete list of past registrants, please click here: Company List


Titles:	The majority of the participants to date have been VPs and Directors. However, the participants have spanned the entire spectrum of the corporate ladder, from the Chairman to the Manager. The following summarizes the titles actually used by past PHARLEX® participants: Chairman Chief Business Officer Chief Executive Officer Chief Financial Officer Chief Operating Officer Chief Scientific Officer Chief Technical Officer Director, Business Development Director, Business Development & Licensing Director, Commercial & Business Development Director, Corporate & Strategic Development Director, Corporate Development Director, Corporate Licensing Director, Development Strategy Planning Director, Global Business Development Director, Licensing Director, Marketing Director, Medical Affairs Director, New Businesses Director, New Products Marketing Director, Operational Planning Director, R&D and International Director, Research and Development Director, Research and Evaluation Director, Scientific Affairs Director, Strategic Alliance Management Director, Technology Assessment and Transfer Director, Technology Search Founder General Manager Head of Business Development Head of Strategy Development Manager, Business Development Manager, Export Manager, External Development Manager, Licensing & Acquisitions Manager, Licensing and Business Development Manager, Strategic Sales Planning Manager, Technology Development Managing Director Partner President VP, Business Development VP, Business Development and Licensing VP, Clinical and Research Development, Licensing VP, Corporate and Business Development VP, Corporate Development VP, External Research VP, In-Licensing VP, International Sales VP, Licensing and Business Development VP, Licensing and Counsel VP, Market and Business Development VP, New Technologies VP, Product Development & Licensing VP, Out-Licensing VP, Sales and Marketing VP, Scientific Affairs

Policies